SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 70 filers reported holding SPERO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 11.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $18,625 | -25.5% | 10,766 | -13.9% | 0.00% | – |
| Q3 2022 | $25,000 | +31.6% | 12,506 | -52.3% | 0.00% | – |
| Q2 2022 | $19,000 | -94.2% | 26,228 | -30.5% | 0.00% | – |
| Q1 2022 | $328,000 | -31.5% | 37,728 | +26.2% | 0.00% | -100.0% |
| Q4 2021 | $479,000 | -45.0% | 29,886 | -36.8% | 0.00% | 0.0% |
| Q3 2021 | $871,000 | +27.2% | 47,316 | -3.6% | 0.00% | 0.0% |
| Q2 2021 | $685,000 | -4.1% | 49,069 | +1.0% | 0.00% | 0.0% |
| Q1 2021 | $714,000 | -24.8% | 48,569 | -0.9% | 0.00% | -50.0% |
| Q4 2020 | $950,000 | +69.3% | 48,988 | -2.5% | 0.00% | +100.0% |
| Q3 2020 | $561,000 | -3.1% | 50,268 | +17.5% | 0.00% | 0.0% |
| Q2 2020 | $579,000 | +63.1% | 42,787 | -2.7% | 0.00% | 0.0% |
| Q1 2020 | $355,000 | +22.8% | 43,996 | +46.5% | 0.00% | 0.0% |
| Q4 2019 | $289,000 | +110.9% | 30,027 | +131.9% | 0.00% | – |
| Q3 2019 | $137,000 | – | 12,949 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,376,968 | $13,247,000 | 23.08% |
| Aquilo Capital Management, LLC | 1,154,356 | $11,099,000 | 4.17% |
| VHCP Management II, LLC | 474,015 | $4,558,000 | 1.20% |
| AWM Investment Company, Inc. | 474,344 | $4,561,000 | 0.89% |
| Alphabet Inc. | 1,112,473 | $10,696,000 | 0.65% |
| BVF INC/IL | 845,405 | $8,129,000 | 0.62% |
| Novo Holdings A/S | 931,099 | $8,948,000 | 0.58% |
| Artal Group S.A. | 500,000 | $4,808,000 | 0.19% |
| Rock Springs Capital Management LP | 525,000 | $5,048,000 | 0.16% |
| Granahan Investment Management | 148,867 | $1,431,000 | 0.07% |